chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sweating; Chills; Headache; Mild fever of 99.2; Slightly sore arm; This spontaneous case was reported by a non-health professional and describes the occurrence of HYPERHIDROSIS (Sweating), VACCINATION SITE PAIN (Slightly sore arm), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Mild fever of 99.2) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.    On 10-Jan-2021 at 10:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced VACCINATION SITE PAIN (Slightly sore arm). On 11-Jan-2021, the patient experienced HYPERHIDROSIS (Sweating), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Mild fever of 99.2). At the time of the report, HYPERHIDROSIS (Sweating), VACCINATION SITE PAIN (Slightly sore arm), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Mild fever of 99.2) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, Body temperature: 99.2 (High) Increased to 99.7.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included Tylenol and ibuprofen.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
1/27/22 pt to hospital with increasing SOB; found to be positive for COVID; acute respiratory failure; treated with steroids; had a non-ST elevation MI and PE; treated with anticoagulants; condition worsened with an increased need for O2; AKI; elevated WBC count; given ABX; required intubation; became hypotensive; WBC count was over 50,000; severe drop in Hemoglobin; given vasopressors; transitioned to comfort care and passed away in the hospital
Lot of pain; Cant raise arm; Didn't sleep all night; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Lot of pain), LIMB DISCOMFORT (Cant raise arm) and INSOMNIA (Didn't sleep all night) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Lot of pain), LIMB DISCOMFORT (Cant raise arm) and INSOMNIA (Didn't sleep all night). At the time of the report, PAIN (Lot of pain), LIMB DISCOMFORT (Cant raise arm) and INSOMNIA (Didn't sleep all night) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details were provided No treatment details were provided
Redness is covering a big zone of almost the half of her upper arm; Arm of the vaccine red; Arm of the vaccine hurting; Arm of the vaccine swollen; Had fever in the arm of the vaccine; Feeling dizzy; Headaches; A spontaneous report was received from a consumer concerning a 57-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced erythema (erythema redness in the arm, redness is covering a big zone of almost the half of her upper arm), vaccination site erythema ( arm of the vaccine red), vaccination site pain (  arm of the vaccine hurting), vaccination site swelling (arm of the vaccine swollen), vaccination site warmth (had fever in the arm of the vaccine), dizziness ( feeling dizzy) and headache.  The patient's medical history was not provided. Concomitant medications reported were Vitamins for unknown indication.  On 6 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 007MZ04) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 20 Feb 2021, the patient stated experiencing arm of the vaccine red, arm of the vaccine swollen, had fever in the arm of the vaccine, arm of the vaccine hurting. On 6 Feb 2021, the patient experienced redness in the arm, redness is covering a big zone of almost the half of her upper arm, feeling dizzy, headaches.  Treatment details included Tylenol.  Action taken with mRNA-1273 in response to the events was not reported.   On 8 Feb 2021 the outcome of event, redness in the arm was resolved. The outcome of other events was unknown.; Sender's Comments: Based on the current available information which shows a temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. Headache, vaccination site erythema, vaccination site swelling and vaccination site pain is consistent with the known safety profile of mRNA-1273..
48 hours after the first dose COVID-19 vaccine, patient had congestion, cough, daily to every other day heavy nose bleeds, and loss of taste and smell. The cough and congestion lasted about 4 days, the nose bleeds lasted 4 to 5 days, and the loss of taste and smell lasted 14 days.
On 09/25/2000 the patient presented with chickenpox that consisted of greater than 50 lesions and no fever. It was indicated that other unspecified patients had similar adverse experiences with the same lot of vaccine, therefore the reporter stated a concern about the lot. Additional information has been requested.
Pt had swelling in the right arm from the shoulder to the elbow. Pt also had pain and in the area and was hot to the touch.
she thought she had pneumonia or COVID; she thought she had pneumonia or COVID; lungs were tightening up; couldn't breathe; extremely tired; sick, really sick; (ALBUTEROL), both for asthma.  Patient had been on fluticasone propionate a long time (reported as 6, 7, 8 or 10 years ago), and was on salbutamol just as long as she has been taking the fluticasone propionate. Before she got COVID she barley used her asthma medications; now she had to use everything daily. No other vaccinations within four weeks prior to the first administration date of the suspect vaccine. No adverse events following prior vaccinations.  A few days afterwards, around 19Mar2021, 20Mar2021, or 21Mar2021. She had a doctors appointment on the 23Mar2021. Patient felt like she experienced a side effect that her lungs were tightening up again.  She was seeing a few doctors right now because she was a "long hauler" because her symptoms were not going away. She was better and then her lungs were tightening up. She was tired all of the time.  She was seeing a Pulmonary specialist, also seeing a heart specialist.  She kept going to the doctor and they kept checking for pneumonia. She said there had been little improvement. She was sick prior and got to feeling better. On 23Mar2021 she got sick and then on 29Mar2021. On 02Apr2021 she got sick and called the doctor because she wasn't feeling good. She went a few times to the doctor and they changed her medicine and things like that. On 08Apr2021 she was sick again and they did an x ray of her lungs and that was better. She stated she was doing therapy and stuff and was getting better. She was followed up for another 6 months. She had a cat scan of her lungs on 11Jun2021 and had ground glass in her lungs. In regards to her lungs, there's another word in there that they can't pronounce. One lobe was clear though. She couldn't breathe, she thought she had pneumonia or COVID, she was extremely tired. The event did not required Emergency Room visit, but resulted in Physician Office visit. Outcome of lungs were tightening up was resolving. Outcome of sick, really sick was not resolved. Outcome of the other events was unknown.  Reporter seriousness assessment for the events was not provided. Patient had not received second dose of COVID (as of 15Jun2021). She stated vaccination card says on there Thursday 2:12 for next one.
Patient received nasal H1N1 vaccine (her 2nd dose) about 0940 2/1/10 and developed a hive-like rash, scattered on arms and legs and chest and face about 1500. Given one dose of Benadryl (3/4 tsp) about 1645. No fever. Exam otherwise unremarkable.
Big bruising for more than 10 days; Red swelling lump for several days; Red swelling lump for several days; First injection on his left arm was administered not intramuscularly but subcutaneous; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (First injection on his left arm was administered not intramuscularly but subcutaneous), CONTUSION (Big bruising for more than 10 days), SWELLING (Red swelling lump for several days) and ERYTHEMA (Red swelling lump for several days) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included Lipoma and Surgery (Had previously surgery because of lipoma on left arm and it can cause the difficulty during administration.). Concomitant products included METOPROLOL, VALSARTAN, ATORVASTATIN, PREDNISONE, AMPICILLIN and ACETYLSALICYLIC ACID (ASPIRINE) for an unknown indication, LEVOTHYROXINE.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (First injection on his left arm was administered not intramuscularly but subcutaneous), SWELLING (Red swelling lump for several days) and ERYTHEMA (Red swelling lump for several days). On 23-Jan-2021, the patient experienced CONTUSION (Big bruising for more than 10 days). On 21-Jan-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (First injection on his left arm was administered not intramuscularly but subcutaneous) had resolved. On 03-Mar-2021, CONTUSION (Big bruising for more than 10 days) had resolved. On 25-Mar-2021, SWELLING (Red swelling lump for several days) and ERYTHEMA (Red swelling lump for several days) had resolved.    Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Fever, redness, sore arm, malaise entire body more than 24 hours post.
This spontaneous report as received from a nurse refers to a 7 months 19 days old male patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) ROTATEQ lot # K016313, exp. date: 31-MAY-2016 and lot # K011663, exp. date: 20-MAY-2016 (dose and strength unspecified) oral. No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
did not get the 3rd dose of GARDASIL 9 on an unspecified date at 6 months; no additional AE reported; This spontaneous report was received from Pharmacist and refers to a 25-year-old female. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date (reported as 0 months), the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided). On an unspecified date (reported as on 2 months), she received the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9).  The patient did not get the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) on an unspecified date at 6 months. No additional adverse events were reported.
It was reported that an adult female patient received a Fluzone SV '01 - '02 vaccination. Lot # UO693AA on 11/11/01. Patient received vaccinet at place of employment by outside health clinic. Patient notified clinic on 11/13/01 that she developed hoarseness that resolved by 11/13/01. Patient not evaluated by physician. No known treatment.
pt recv vax 8APR96 & 21MAR96 pt devel rash & itching on face, neck & trunk;fever of 99 x 1 day;joint pain in hands & wrists;mild swelling;24MAR96 pt exp tingling & red eyes;26mar96 pt had 99.3T seen at dr office
On 3/28 I woke up with a ache on left side of face and paralysis on left side of face and went to the doc. Was diagnosed with bells palsy. The left side had trouble speaking eating slur speech and had to wear a patch over eye. Had a terrible pain on the back of neck. Was prescribe Lyrica and oral steroids'. I am still suffering from it. The steroid treatment cause eyes to have cataracts. Vaccine card does not have lot number on it.
I got my shot, then I went to work at my job (same place as vaccination) at the door. I started getting sort of dizzy and had to sit down and lay my head down. My boss made me come in and lay down and call my husband to take me home. I took about 3 (paid) days off. That's about it, I went home and went to bed. I had arm pain almost immediately and it started as an annoying pain, and it increased throughout the day. The pain last about 4 months, I felt it all the way around the arm. I didn't go into doctor for the first dose. But I went in for my yearly mammogram with the doctor about a month or two ago (Feb/March 2022) and there were 2 or 3 masses in my left breast during the mammogram. He sent me to another doctor at another facility who did an ultrasound to get a closer look and said that it was swollen lymph nodes, and who knows how long they had been swollen like that. He said it wasn't the first time he had seen that from the vaccine. If they're still swollen, I don't know. He said it was nothing for me to worry about.
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown age and gender. The physician reported that on an unknown date patients were vaccinated with (Merck) VARIVAX (lot # and expiration date unspecified) (dose, route and anatomical location unspecified). Physician stated that patients had received (merck) VARIVAX two and three times (unspecified dates) and were showing negative titers (unknown date) using standard lab varicella testing. At the time of the report, the outcome of patients was unknown. Additional information has been requested.
Child was given flu vaccine in office. Upon leaving her appointment, she fainted in the reception area hallway.
This spontaneous report was received from a health care worker and a licensed nurse practitioner refers to a patient of unspecified age and gender. On 25-JUL-2013, the patient was vaccinated with a dose of improperly stored (Oka/Merck) VARIVAX (lot # H018786, exp date: 15-OCT-2014, 0.5 milliliter (ml), subcutaneous) (strength and indication not reported). The (Oka/Merck) VARIVAX had been stored at -10 C (celsius) (above recommended temperature range in product information) since July 2013. No adverse effects reported. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Athsma attack, really bad. Felt like I couldn't breath. Athsma bad for 2 days even with my inhalers.
Pt developed swelling in both feet and legs and the top of feet were painful. Pt was seen in follow-up ten days later. Cysts were identified bilaterally. Pt was referred to orthopedist. Follow up letter states that the lot number to the vaccine was not listed in patient's chart.
Client vaccinated with Moderna vaccines for Covid on 3/16 and 4/18/2021.  Symptoms started on 12/10 - cough, fatigue, headache, myalgia, nausea.
Chills; Weakness; Tired; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 12Mar2021 at 14:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. On 13Mar2021 at 22:00, the patient experienced chills, weakness and tired. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, weakness and tired were resolved on an unknown date in Mar2021.   No follow-up attempts are possible. No further information is expected.
he developed a bad hemorrhoid; This is a spontaneous report from a contactable consumer (patient). A 68-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 29Jan2021 as DOSE 1, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in 2021, The patient on developed a bad haemorrhoid. Reportedly, the patient received his first dose of the Pfizer COVID vaccine three weeks ago from the time of reporting. The patient was scheduled to receive his second dose. The patient developed a bad haemorrhoid and his physician prescribed hydrocortisone topical cream. The patient states that he read somewhere that oral cortisone may have an effect on the efficacy of the vaccine. The patient would like to know whether topical hydrocortisone will have an effect on the efficacy of the vaccine. Outcome of the event was unknown.  Information about lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
PATIENT HAD PFIZER VACCINE DOSES, Dose 1 date: 01/19/2021,  Dose 2 date: 02/10/2021. PATIENT TESTED POSITIVE TO COVID.
Pt had given Covid vaccine age 5-11yrs old instead of 11yr up dose. MA has given pt the wrong vaccine
Missed abortion noted about one month after 1st COVID vaccination Patient was supposed to be around 11weeks pregnant. She had a prior ultrasound with a single live intrauterine pregnancy on Feb 24, 2021. EDD was October 3rd, 2021. Fetus with no heart tones noted on March 17th, 2021. Fetus measuring about 8 weeks pregnant  patient only noted elevated temperature after COVID vaccination
Full body red raised spotted rash with bloches of large red patches on the the upper arms. Itchy   Treated with steroids and H2 blockers
4/5/22 PMH of DVT formerly on warfarin, hypertension, and recent subdural hemorrhage. Presents to the emergency department with complaints of left lower extremity weakness and altered mental status.
Diagnosed with temporal lobe epilepsy on 6/22/2021. My very 1st seizure ever.
Pregnant woman was inadvertently administered Fluad; Pregnant woman was inadvertently administered Fluad; This spontaneous case was received on 02-Oct-2023 from a health care professional via Communications (reference number: SEQW23-02853) and concerned a pregnant female patient of unreported age.  The patient's medical history included In vitro fertilization (IVF) pregnancy. The patient had no concomitant medications.   The patient's obstetrical history did not include previous pregnancies. The patient's estimated delivery date (EDD) was reported as 09-Dec-2023. The patient's last menstrual period (LMP) date, and corrected estimated date of delivery (CEDD) were not reported. Type of pregnancy was reported as IVF pregnancy (in vitro fertilisation).  On 02-Oct-2023, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine inact sag 4v; dose: 0.5 ml; route of administration, anatomical location: not reported) for active immunization against influenza disease for people 65y and older, as reported (explicitly coded as 'Vaccine exposure during pregnancy' and 'Inappropriate age at vaccine administration'). The batch number reported was 370677, and expiry date: 10-May-2024.  At the time of the initial reporting, the patient did not have any reaction following the vaccination with Fluad Quadrivalent vaccine.  Company comment: A pregnant female patient of unreported age was vaccinated with Fluad Quadrivalent (explicitly coded as: 'Product administered to patient of inappropriate age' and 'Vaccine exposure during pregnancy'). The patient's medical history included in vitro fertilization (IVF). The patient's estimated delivery date (EDD) was reported as 09-Dec-2023, and obstetrical history did not include previous pregnancies. Reportedly, type of the pregnancy is IVF pregnancy. Patient's last menstrual period (LMP) and corrected date of delivery (CEDD) were not reported. The patient did not have any reaction following vaccination. Causality for product administered to patient of inappropriate age and vaccine exposure during pregnancy is assessed as not related as per company's conventions.; Sender's Comments: A pregnant female patient of unreported age was vaccinated with Fluad Quadrivalent (explicitly coded as: 'Product administered to patient of inappropriate age' and 'Vaccine exposure during pregnancy'). The patient's medical history included in vitro fertilization (IVF). The patient's estimated delivery date (EDD) was reported as 09-Dec-2023, and obstetrical history did not include previous pregnancies. Reportedly, type of the pregnancy is IVF pregnancy. Patient's last menstrual period (LMP) and corrected date of delivery (CEDD) were not reported. The patient did not have any reaction following vaccination. Causality for product administered to patient of inappropriate age and vaccine exposure during pregnancy is assessed as not related as per company's conventions.
Rash in both arms; This spontaneous case was reported by a nurse and describes the occurrence of RASH (Rash in both arms) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced RASH (Rash in both arms). On 01-May-2021, RASH (Rash in both arms) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   patient did not taken any treatment for the event.
short-term memory problems , dizziness , slurred speech for 3 months  He has short-term memory problems before that and per patient he took an 8-hour test and his score was similar to 6 grade level.  Short-term memory problems are forgetting peoples names but not so much faces and some language problems and walking into the room and not remembering why he went there, the latter symptom is particular new and not old.  About once a week he has lightheadedness where he could be sometimes walking or sometimes in the shower and like he is going to pass out but does not and it is very transient quickly.  Pt is well-hydrated.  Rare alcohol no illicits no tobacco.  Slurred speech happens about once a day for 10 to 20 seconds per patient and is brand-new over the last 3 months. Denies facial droop or weakness.